Next Article in Journal
Non-Invasive Assessment of Isocitrate Dehydrogenase-Mutant Gliomas Using Optimized Proton Magnetic Resonance Spectroscopy on a Routine Clinical 3-Tesla MRI
Previous Article in Journal
Clinicopathological Factors Associated with Oncotype DX Risk Group in Patients with ER+/HER2- Breast Cancer
Previous Article in Special Issue
Preclinical and Basic Research Strategies for Overcoming Resistance to Targeted Therapies in HER2-Positive Breast Cancer
 
 
Communication

Article Versions Notes

Cancers 2023, 15(18), 4452; https://doi.org/10.3390/cancers15184452
Action Date Notes Link
article xml file uploaded 7 September 2023 09:41 CEST Original file -
article xml uploaded. 7 September 2023 09:41 CEST Update -
article pdf uploaded. 7 September 2023 09:41 CEST Version of Record -
article html file updated 7 September 2023 09:42 CEST Original file -
article xml file uploaded 7 September 2023 11:04 CEST Update -
article xml uploaded. 7 September 2023 11:04 CEST Update -
article pdf uploaded. 7 September 2023 11:04 CEST Updated version of record -
article html file updated 7 September 2023 11:07 CEST Update -
article html file updated 7 September 2023 11:07 CEST Update -
article html file updated 7 September 2023 11:10 CEST Update -
article xml file uploaded 7 September 2023 11:23 CEST Update -
article xml uploaded. 7 September 2023 11:23 CEST Update https://www.mdpi.com/2072-6694/15/18/4452/xml
article pdf uploaded. 7 September 2023 11:23 CEST Updated version of record https://www.mdpi.com/2072-6694/15/18/4452/pdf
article html file updated 7 September 2023 11:24 CEST Update -
article html file updated 7 September 2023 11:29 CEST Update https://www.mdpi.com/2072-6694/15/18/4452/html
Back to TopTop